Table S1. ORs for new-onset metabolic syndrome components according to baseline DPP4 activity (nmol/ml/min); Table S2. ORs for new-onset metabolic syndrome components according to baseline active GLP-
Beta cell dysfunction accompanies and drives the progression of type 2 diabetes mellitus (T2D), but there are few clinical biomarkers available to assess islet cell stress in humans. Secretagogin, a p
Nonenzymatic glycation of proteins sets the stage for formation of advanced glycation end-products and development of chronic complications of diabetes. In this report, we extended our previous method
